Simple blood test could predict lymphoma treatment success
NCT ID NCT07480837
Summary
This study is testing whether tracking lymphoma DNA in blood can help predict how well treatment is working. Researchers will collect blood samples from 60 lymphoma patients before, during, and after treatment to see if changes in this DNA match up with scan results and long-term outcomes. The goal is to develop a less invasive way to monitor treatment response and predict which patients might need different approaches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL NON HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China
Conditions
Explore the condition pages connected to this study.